HOME >> MEDICINE >> NEWS
Cardiovascular disease costs UK economy 29 billion a year

Cardiovascular disease costs the UK economy 29 billion a year in healthcare expenditure and lost productivity, reveals research published ahead of print in Heart.

The UK spends more of its healthcare budget on cardiovascular disease than any other country in the European Union, the figures show.

The research team from the Health Economics Research Centre at the University of Oxford base their calculations on all UK residents with diagnosed cardiovascular disease in 2004 and associated costs.

These included community health and social services, emergency care, hospital stays, informal care, and the impact on productivity from illness and premature death.

When all these factors were added up, the total costs to the UK economy of cardiovascular disease in 2004 came to 29 billion.

The largest component was healthcare, which accounted for 60% of the total. Lost productivity accounted for 23% and informal care cost 17%.

Cardiovascular disease and cost the NHS almost 16 billion in 2004, representing 21% of all healthcare expenditure. Private healthcare costs add almost 1.5 billion to the tally, representing 18% of overall UK healthcare costs.

These figures represent the highest proportion of healthcare expenditure on cardiovascular disease of any country in the European Union.

Hospital inpatient care was the most expensive component at almost 10 billion or nearly two thirds of the NHS bill for cardiovascular disease.. Drug costs amounted to almost 3 billion.

More than 69 million work days were lost to the disease in 2004, at a cost to the UK economy of almost 3 billion.

An accompanying editorial suggests that despite the falling rates of illness and death from cardiovascular disease, cost savings are likely to be cancelled out by the rising costs of treatment, the ageing of the population, and the threat to heart health posed by obesity and diabetes


'"/>

Contact: Emma Dickinson
edickinson@bmj.com
44-207-383-6529
BMJ Specialty Journals
14-May-2006


Page: 1

Related medicine news :

1. Cardiovascular flow disturbances study aimed at improving diagnosis and treatment
2. Bluhm Cardiovascular Institute surgeons implant heart pump in comparative study of two devices
3. Cardiovascular drug may improve heart failure and help prevent sudden death
4. A broader look at cardiac CTA images often finds diseases/disorders beyond the heart
5. Smoking may strongly increase long-term risk of eye disease
6. Pot bellies linked to early signs of cardiovascular disease
7. Anemia and tropical diseases; Is pharmacogenomics ready for the clinic?
8. 1 of 2 pediatric kidney disease research centers in world established
9. Reductive stress linked to heart disease
10. Obesity linked to hyperparathyroidism in chronic kidney disease
11. Wireless technology shows promise in diagnosing pediatric intestinal disease

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Cardiovascular disease costs economy billion year

(Date:5/21/2013)... The Special Olympics Missouri State Summer Games ... the state to Columbia. This state-level event takes place May ... and Columbia College, and at Hickman High School and Town ... kick off at 7:30 p.m. Friday, May 30 with the ... theme, the Parade of Athletes, the culmination of the statewide ...
(Date:5/21/2013)... Venice Beach, Calif. (PRWEB) May 21, 2013 ... to treating a dual diagnosis of Borderline Personality Disorder ... therapy that is proving to be successful for the ... Saturday, June 1, Alina Gorgorian, Ph.D., clinical director ... treatment in Los Angeles, will provide attendees of ...
(Date:5/21/2013)... autism showed significant improvement after six months of simple ... scents, spoons and sponges, according to UC Irvine neurobiologists. ... enrichment led to notable gains in male subjects between ... in Behavioral Neuroscience . , Study co-authors Cynthia ... one of two groups, balanced for age and autism ...
(Date:5/21/2013)... 2013 STAR (Sensory Therapies And ... with sensory challenges and the Sensory Processing Disorder ... and advocacy of Sensory Processing Disorder present Stumbling Blocks ... Improve Quality of Life, a two-hour lecture presented by ... , Learn a method that can aid in ...
(Date:5/21/2013)... Chicago, IL (PRWEB) May 21, 2013 ... business process integration solutions, today announced it is the ... by analyst firm 451 Research. The report, “Adeptia Bets ... in-depth review of the company, its strategy, products, pricing, ... are in need of a framework for integration and ...
Breaking Medicine News(10 mins):Health News:Special Olympics Missouri Athletes Ready to Show Off Skills in Columbia 2Health News:Special Olympics Missouri Athletes Ready to Show Off Skills in Columbia 3Health News:Clearview Treatment Programs Clinical Director to Present on DBT and Substance Abuse at WCSAD 2Health News:Clearview Treatment Programs Clinical Director to Present on DBT and Substance Abuse at WCSAD 3Health News:Enrichment therapy effective among children with autism, UCI study finds 2Health News:STAR Center and SPD Foundation Present a Lecture on Teens and Adults with Sensory Processing Disorder 2Health News:STAR Center and SPD Foundation Present a Lecture on Teens and Adults with Sensory Processing Disorder 3Health News:Adeptia Featured in Recent 451 Research Impact Report 2
(Date:5/21/2013)... May 21, 2013   Accuray Incorporated ... publication of study results involving hundreds of prostate ... System, the most widely used form of prostate ... 304 patients for a median of 5 years, ... that 97 percent of patients with low-risk and ...
(Date:5/21/2013)... Fla. , May 21, 2013  Janssen ... safety results from the global Phase 3 PROMISE ... inhibitor simeprevir (TMC435) led to sustained virologic response ... in 79 percent of treatment-experienced genotype 1 chronic ... including all stages of liver fibrosis, when administered ...
(Date:5/21/2013)... 21, 2013 Abaxis, Inc. (NasdaqGS: ABAX), a ... today that Martin Mulroy , chief ... Dental & Veterinary Conference on Wednesday, May 29, 2013 ... at Le Parker Meridien Hotel in New ... Abaxis develops, manufactures, markets and sells portable blood ...
Breaking Medicine Technology:New Data Validates CyberKnife SBRT for Prostate Cancer Treatment 2New Data Validates CyberKnife SBRT for Prostate Cancer Treatment 3Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 2Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 3Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 4Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 5Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 6Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 7Abaxis, Inc. to Present at the Stifel Annual Dental & Veterinary Conference 2
Cached News: